Literature DB >> 1702714

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

A Christensson1, C B Laurell, H Lilja.   

Abstract

Prostate-specific antigen (PSA) is one of the three most abundant prostatic-secreted proteins in human semen. It is a serine proteinase that, in its primary structure, manifests extensive similarities with that of the Arg-restricted glandular kallikrein-like proteinases. When isolated from semen by the addition of chromatography on aprotinin-Sepharose to a previously described procedure, PSA displayed chymotrypsin-like activity and cleaved semenogelin and the semenogelin-related proteins in a rapid and characteristic pattern, but had no trypsin-like activity. About one third of the purified protein was found to be enzymatically inactive, due to cleavage carboxy-terminal of Lys145. Active PSA formed SDS-stable complexes with alpha 1-antichymotrypsin, alpha 2-macroglobulin-analogue pregnancy zone protein. PSA formed inhibitory complexes with alpha 1-antichymotrypsin at a molar ratio of 1:1, a reaction in which PSA cleaved the inhibitor in a position identical to that reported from the reaction between chymotrypsin and alpha 1-antichymotrypsin. The formation of stable complexes between PSA and alpha 1-antichymotrypsin occurred at a much slower rate than that between chymotrypsin and alpha 1-antichymotrypsin, and at a similar or slightly slower rate than that between PSA and alpha 2-macroglobulin. When added to normal blood plasma in vitro, active PSA formed stable complexes both with alpha 2-macroglobulin and alpha 1-antichymotrypsin. This complex formation may be a crucial determinant of the turnover of active PSA in intercellular fluid or blood plasma in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702714     DOI: 10.1111/j.1432-1033.1990.tb19466.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  85 in total

1.  Expression and characterization of trypsinogen produced in the human male genital tract.

Authors:  A Paju; A Bjartell; W M Zhang; S Nordling; A Borgström; J Hansson; U H Stenman
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

Authors:  Yue Cao; Ake Lundwall; Virgil Gadaleanu; Hans Lilja; Anders Bjartell
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Authors:  Gabriela De Angelis; Harry G Rittenhouse; Stephen D Mikolajczyk; L Blair Shamel; Axel Semjonow
Journal:  Rev Urol       Date:  2007

4.  Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring.

Authors:  Akos Végvári; Karin Sjödin; Melinda Rezeli; Johan Malm; Hans Lilja; Thomas Laurell; György Marko-Varga
Journal:  Mol Cell Proteomics       Date:  2013-07-10       Impact factor: 5.911

5.  Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.

Authors:  Z Zhou; E G Armstrong; A Belenky; J V Freeman; K K Yeung
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

6.  Development of an immunoassay specific for the PSA-ACT complex without the problem of high background.

Authors:  J T Wu; P Zhang; G H Liu; L Wilson
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

7.  Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma.

Authors:  M Cetinkaya; S Günçe; E Ulusoy; F Aksoy; O Yildiz; O Adsan; C Ozden
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

8.  Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution.

Authors:  Oskar Vilhelmsson-Timmermand; Elmer Santos; Daniel L J Thorek; Susan Evans-Axelsson; Anders Bjartell; Hans Lilja; Steven M Larson; Sven-Erik Strand; Thuy A Tran; David Ulmert
Journal:  Nucl Med Biol       Date:  2014-12-23       Impact factor: 2.408

9.  Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.

Authors:  Jeremy G Stone; Raj K Rolston; Masumi Ueda; Hyoung-Gon Lee; Sandy L Richardson; Rudy J Castellani; George Perry; Mark A Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-10-20

10.  The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study.

Authors:  Helena P Burden; Chris R Davis; Sophie Tate; Raj Persad; Chris H Holmes; Kate Whittington
Journal:  BMC Urol       Date:  2008-11-20       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.